FCA Corp’s Novo Nordisk NVO Stock Holding History

FCA Corp’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,000	Closed	-$204K	–	195
2025 Q4	$204K	Hold	4,000	–	–	0.06%	182
2025 Q3	$222K	Hold	4,000	–	–	0.06%	173
2025 Q2	$276K	Hold	4,000	–	–	0.08%	155
2025 Q1	$278K	Hold	4,000	–	–	0.09%	147
2024 Q4	$571K	Hold	4,000	–	–	0.18%	111
2024 Q3	$476K	Hold	4,000	–	–	0.15%	127
2024 Q2	$571K	Hold	4,000	–	–	0.18%	117
2024 Q1	$514K	Hold	4,000	–	–	0.17%	124
2023 Q4	$414K	Hold	4,000	–	–	0.14%	128
2023 Q3	$364K	Hold	4,000	–	–	0.14%	127
2023 Q2	$324K	Hold	4,000	–	–	0.12%	137
2023 Q1	$318K	Hold	4,000	–	–	0.12%	131
2022 Q4	$271K	Buy	+4,000	New	+$235K	0.11%	132
2022 Q3	–	Sell	-4,000	Closed	-$223K	–	177
2022 Q2	$223K	Hold	4,000	–	–	0.09%	150
2022 Q1	$222K	Hold	4,000	–	–	0.08%	163
2021 Q4	$224K	Buy	+4,000	New	+$217K	0.08%	168

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

FCA Corp's NVO Position: Q1 2026 in Review

FCA Corp sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,000 shares — an estimated $204K sold.

FCA Corp first reported a position in NVO in Q4 2021 and held it in 16 quarters. The position peaked at $571K in Q4 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

FCA Corp reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
FCA Corp sold 4,000 Novo Nordisk shares in Q1 2026, an estimated $204K.
FCA Corp first reported a position in Novo Nordisk in Q4 2021 and held it in 16 quarters.
FCA Corp's Novo Nordisk position peaked at $571K in Q4 2024.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on FCA Corp's 13F filing for Q1 2026, filed 14 May 2026.